Search Results for: lung cancer

Rosetta Genomics Ltd, Israel and Jersey City, NJ, reports its molecular test based on proprietary microRNA technology has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.

BioTrove Inc, Woburn, Mass, and Gene Express Inc, Toledo, Ohio, have received a two-year National Institutes of Health grant for their proposed novel research of genetic biomarkers for lung cancer.

Rosetta Genomics Ltd, Israel, which develops microRNA-based diagnostics and therapeutics, has signed a binding term sheet for $2.9 million to purchase Parkway Clinical Laboratories Inc, Bensalem, Pa, a privately owned CLIA-certified lab.

Irregular molecules in the lining of the mouth, the saliva, the fallopian tube, or the bladder can identify early stage cancer, according to research presented this week at the annual meeting of the American Association for Cancer Research.

Genetic variations ensure no two people or their cancers are identical, and researchers may provide more precise and effective treatment wielding tools and knowledge that predict how individuals will respond to cancer therapy.